Differences in sustained virological response (SVR) based on treatment duration, demographics and best responses to previous treatment are displayed in Table 12.

2log10 decline in HCV RNA 2log10 decline in HCV RNA Missing best previous response

a) Without cirrhosis

You should not be treated with PhotoBarr if you have severe liver disease (eg cirrhosis)

Chronic hepatitis with decompensated cirrhosis of the liver.

Epilepsy and or compromised central nervous system (CNS) function (see section 4.4).

A total of 283 1351 (21 ) of patients had advanced fibrosis or cirrhosis, 85 1351 (6 ) had cirrhosis.

A total of 283 1351 (21 ) of patients had advanced fibrosis or cirrhosis, 85 1351 (6 ) had cirrhosis.

This alcohol can be responsible for cirrhosis.

Hypersensitivity to the active substances, to any of the excipients (see section 6.1), or to other sulfonamide derived substances (hydrochlorothiazide is a sulfonamide derived substance) Second and third trimester of pregnancy (see sections 4.4 and 4.6) Lactation (see section 4.6) Severe renal impairment (creatinine clearance 30 ml min) Refractory hypokalaemia, hypercalcaemia Severe hepatic impairment, biliary cirrhosis and cholestasis

Severe renal impairment (creatinine clearance 30 ml min), Refractory hypokalaemia, hypercalcaemia, Severe hepatic impairment, biliary cirrhosis and cholestasis.

Severe hepatic impairment, biliary cirrhosis and cholestasis.

(including hepatocarcinoma).

He died suddenly of cirrhosis of the liver.

Study NV15495 specifically recruited patients with a histological diagnosis of cirrhosis (about 80 ) or transition to cirrhosis (about 20 ).

Study NV15495 specifically recruited patients with a histological diagnosis of cirrhosis (about 80 ) or transition to cirrhosis (about 20 ).

Patients with cirrhosis with decompensation There are no efficacy and safety data in patients with decompensated cirrhosis.

4 Patients with cirrhosis without decompensation Due to the limited data available (about 3 of patients enrolled had cirrhosis), telbivudine should be used with particular caution in cirrhotic patients.

18 Patients with cirrhosis without decompensation Due to the limited data available (about 3 of patients enrolled had cirrhosis), telbivudine should be used with particular caution in cirrhotic patients.

Severe hepatic dysfunction or decompensated cirrhosis of the liver

Severe hepatic dysfunction or decompensated cirrhosis of the liver.

(including hepatocarcinoma).

Severe hepatic impairment, biliary cirrhosis or cholestasis.

score 6.

patients with liver cirrhosis and or ascites

patients with liver cirrhosis and or ascites

Severe hepatic impairment (with or without cirrhosis) (see section 4.2).

And of course I wanted to, who would want to die from liver cirrhosis?

The liver, if neglected, invariably leads to cirrhosis

Decompensated cirrhosis a higher rate of serious hepatic adverse events has been observed in patients with decompensated cirrhosis compared with rates in patients with compensated liver function.

Infections and infestations Hepatobiliary disorders Psychiatric disorders

score 6.

No patients in either group progressed to cirrhosis.

Shevchenko died of cirrhosis of the liver on February 28, 1998, and was buried in Washington, DC.

Severe hepatic dysfunction, including hepatic failure, cirrhosis, portal hypertension

Severe hepatic dysfunction, including hepatic failure, cirrhosis, portal hypertension

Severe hepatic dysfunction, including hepatic failure, cirrhosis, portal hypertension

32 Patients with hepatic impairment In patients with compensated cirrhosis (eg, Child Pugh A), Pegasys has been shown to be effective and safe.

58 Patients with hepatic impairment In patients with compensated cirrhosis (eg, Child Pugh A), Pegasys has been shown to be effective and safe.

84 Patients with hepatic impairment In patients with compensated cirrhosis (eg, Child Pugh A), Pegasys has been shown to be effective and safe.

Child Pugh score 6.

Patients with decompensated cirrhosis a higher rate of serious hepatic adverse events has been observed in patients with decompensated cirrhosis compared with rates in patients with compensated liver function.

Chaplin's father died two years later, at 38 years old, from cirrhosis of the liver.

Pegasys has not been evaluated in patients with decompensated cirrhosis (eg, Child Pugh B or C or bleeding oesophageal varices) (see section 4.3).

In a clinical trial of non responder patients to prior pegylated interferon alfa 2b ribavirin, which exposed patients to either 48 or 72 weeks of treatment, the frequency of withdrawal for adverse events or laboratory abnormalities from Pegasys treatment and ribavirin treatment was 6 and 7 , respectively, in the 48 week arms and 12 and 13 , respectively, in the 72 week arms.